Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F3UBV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,133
Award facts
- Contract value 100% obligated
- $21,132.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $21,132.74 by the Defense Logistics Agency on January 21, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 22, 2026, to be fulfilled at the company's facility in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in delivering a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for Trelegy Ellipta, a respiratory medication used in chronic obstructive pulmonary disease treatment, exemplifies the company's role in supplying essential prescription medications to federal medical procurement needs through open competition with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DR26F3UBV?
SPE2DR26F3UBV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F3UBV worth?
The government has obligated $21,133 on SPE2DR26F3UBV.
Is contract SPE2DR26F3UBV an order under another contract?
Yes. SPE2DR26F3UBV is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UBV competed?
The extent of competition for SPE2DR26F3UBV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award